pJEK11 is a derivative of pET15b with the open reading frame encoding the human beta-synuclein (ÄÂĂÂ-synuclein) cloned in via the NdeI and BamHI restriction sites. In this construct ÄÂĂÂ-synuclein is expressed as a fusion protein with an N-terminal six His tag.
Additional notes:
Beta-synuclein is an abundant pre-synaptic phosphoprotein that is found in the brain and is homolgous to alpha-synuclein. Beta-synuclein is distinct from alha-synuclein in that it lacks the majority of the hydrophobic non-amyloid-beta component of the Alzeheimer’s disease amyloid region. Due to this beta-synuclein is less likely to form insoluble aggregates when compared to alpha-synuclein. It is thought that beta-synuclein may have a protective role against alpha-synucleinopathies.
Beta-synuclein is an acidic, neuronal protein considered to be a non-amyloidogenic homolog of alpha-synuclein. It has been postulated that beta-synuclein could act as a physiological inhibitor of α-synuclein aggregation and thus protect the central nervous system from the neurotoxic effects of alpha-synuclein
Cat. #:
152049
Research Fields:
Neurobiology
Application notes:
pJEK11 is a derivative of pET15b with the open reading frame encoding the human beta-synuclein (β-synuclein) cloned in via the NdeI and BamHI restriction sites. In this construct β-synuclein is expressed as a fusion protein with an N-terminal six His tag.
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
